Influence of the polymorphism of apolipoprotein E in cerebral vascular disease

Arquivos de Neuro-Psiquiatria

Volumn 61, Issue 1, 2003, Pages 7-13

  Souza, Dorotéia R S ^a,c   Campos, Bernadete F ^a   De Arruda, Érika F ^a   Yamamoto, Lucy J ^a   Trindade, Daniel M ^a   Tognola, Waldir A ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FAPESP   (Brazil)

^c NONE   (Brazil)

Author keywords

Apolipoprotein E; Atheromathosis; Lipid profile; Stroke

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BRAIN ATHEROSCLEROSIS; CEREBROVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENOTYPE; HUMAN; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PROTEIN POLYMORPHISM; RISK FACTOR; STROKE; THROMBOSIS;

EID: 0037350940     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0004-282X2003000100002     Document Type: Article

References (27)

1. Adams RD, Victor M. Doenqas Cerebrovasculares. In Adams RD, Victor M Princípios de neurologia, 5.Ed. Rio de Janeiro: Nueva Editorial Interamericana; 1996:481-536.
2. Saposnik G, Terzaghi MA. Genetical aspects in cerebrovascular disease. Rev Neurol 1999;28:1098-104.
3. Cumming AM, Robertson F. Polymorphism at the apo E locus in relation to risk of coronary disease. Clin Genet 1984;25:310-313.
4. Lenzen HJ, Assmann G, Buchwalsky R, Schulte H. Association of apolipoprotein E polymorphism, low density lipoprotein, and coronary artery disease. Clin Chem 1986;32:778-781.
5. Kuusi T, Nieminen MS, Ehnholm C, et al. Apolipoprotein E polymorphism and coronary artery disease: angiographically verified coronary patients. Arteriosclerosis 1989;9:237-241.
6. Marin DB, Breur B, Marin ML, et al. The relationship between apolipoprotein E, dementia, and vascular illness. Atherosclerosis 1998;140:173-180.
7. McCarron MO, Delong D, Alberts MJ. Apolipoprotein E genotype as a risk factor for ischemic cerebrovascular disease: a meta-analysis. Neurology 1999;53:1308-1311.
8. DeCarli C, Reed T, Miller BL, Wolf P, Swan GE, Carmelli D. Impact of apolipoprotein E epsilon 4 and vascular disease on brain morphology in men from the NHLBI twin Study. Stroke 1999;8:1548-1553.
9. Gould AL, Rossouw JE, Santanello NC, Heyse JF, Fuberg CD. Cholesterol reduction yelds clinical benefit: impact of statin trials. Circulation, 1998;17;97:946-952.
10. Wu LH, Wu JT, Hopkins P. Apolipoprotein E: laboratory determinations and clinical significance. In Rifai N, Warnick GH, Dominiczak MH (eds) Handbook of lipoprotein testing. Washington: AACC Press, 1997:598.
11. Pedro-Botet J, Sentì M, Nogues X, et al. Lipoprotein and apolipoprotein profile in men with ischemic stroke: role of lipoprotein (a), triglyceride-rich lipoproteins and apoprotein E polymorphism. Stroke 1992;23:1556-1562.
12. Margaglione M, Seripa D, Gravina C, et al. Prevalence of apoprotein E in healthy subjects and survivors of ischemic stroke. Stroke 1998;29:399-403.
13. Peng DK, Zhao SP, Wang JL. Lipoprotein (a) and apolipoprotein E epsilon 4 as independent risk factors for ischemic stroke. J. Cardiovasc Risk 1999;6:1-6.
14. Ferrucci L, Guralnik JM, Pahor M, et al. Apolipoprotein E ε2 allele and risk of stroke in the older population. Stroke 1997;28:2410-2416.
15. Nakata Y, Katsuya T, Rakugi H, Takami S, Noriyuki S, Kamide K. Polymorphism of angiotensin converting enzyme, angiotensinogen, and apolipoprotein E genes in a Japanese population with cerebrosvacular disease. Am J Hypert 1997;10:1391-1395.
16. Cao W, Chen F, Teng L, Wang S, Fu S, Zang G. The relationship between apolipoprotein E gene polymorphism and coronary heart disease and arteriosclerotic cerebral infarction. Chung Hua I Hsueh I Chuan Hsueh Tsa Chih 1999;4:249-251.
17. Catto AJ, Mc Cormack LJ, Mansfield MW, et al. Apolipoprotein E polymorphism in cerebrovascular disease. Acta Neurol Scand 2000;101:399-404.
18. Sociedade Brasileira de Cardiologia. 2.° Consenso Brasileiro sobre Dislipidemias Arq Bras Card 1996;67:3.
19. Adams HP Jr, Bendixen BH, Kappelle LJ, et. al. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. Stroke 1993;24:35-41.
20. Gustincich S, Manfioletti G, Del San G, Schnider C. A fast method for high-quality genomic DNA extraction from whole human blood. BioTech 1991;11:298-301.
21. McCarron MO, Muir KW, Nicoll JA, et al. Prospective study of apolipoprotein E genotype and functional outcome following ischemic stroke. Arch Neurol 2000;57:1480-1484.
22. Guilling H, Kontula K, Miettinen TA. Cholesterol absorption and metabolism and LDL cinetics in healthy men with different apoprotein E phenotypes and apoprotein B Xba I and LDL receptor Pvu II genotypes. Arterioscler Thromb Vasc Biol 1995;15:208-213.
23. Utermann G, Jaeschke M, Menzel J. Familial hyperlipoproteinemia type III: deficiency of a specific apolipoprotein (Apo E3) in very low density lipoproteins. FEBS 1975;56:352-355.
24. Lehtimaki T, Moilanen T, Nikkari T, et al. Regional differences in apolipoprotein E polymorphism in Finland. Ann Med 1991;23:61-66.
25. Pablo-Mendez, Mayeux R, Nagai C, et al. Association of apo E polimorphism with plasma levels in multiethnic elderly population. Arterioscl Thromb Vasc Biol 1997;17:3534-3541.
26. Aguilar CA, Talavera G, Ordovas JM, et al. The apolipoprotein E4 allele is not associated with an abnormal lipid profile in a native american population following its traditional lifestyle. Atherosclerosis 1999;142:409-414.
27. Tomimoto H, Akiguchi I, Suenaga E, Wakita H, Nakamura S, Kimura J, et al. Immunohistochemical study of apolipoprotein E in human cerebrovascular white matter lesions. Acta Neuropathol 1995;90:608-614.